Emergency department (ED) patients who are admitted with myocardial infarction, sepsis, or respiratory conditions have a higher risk of unplanned transfer to the intensive care unit (ICU) within 24 hours than ... hours. The admitting diagnoses most
Death or myocardial infarction occurred in 1,419 patients (11%) receiving a proton-pump inhibitor compared with 1,341 patients (8%) who were not. ... There was no association with myocardial infarction for other 2C19 inhibitors/non-inhibitors.
T]he long-term consequences of such recommendations are unclear,” they wrote. A single measurement of high-sensitivity cardiac troponin T and an electrocardiogram (EKG) may rule out acute myocardial infarction ... The latter were defined as stroke or
For atrial fibrillation patients who had myocardial infarction (MI) or percutaneous coronary intervention (PCI), triple antithrombotic therapy carries a higher risk of bleeding than other regimens, and should be used cautiously,
Post-myocardial infarction inpatients with blood potassium levels between 3.5 and 4.5 mEq/L had a lower mortality risk than those with levels higher or lower than this range, ... Current guidelines recommend maintaining serum potassium levels between 4.0
The median 30-day risk-standardized mortality rates for myocardial infarction (MI) were 9.4% for patients ages 65 years and older, 3.0% for those ages 18 to 64 years, ... Hospital rankings based on myocardial infarction (MI) mortality rates only for
Diabetics benefit less from receiving clopidogrel after myocardial infarction (MI) than non-diabetics, a study found.
More than 40% of 30-day rehospitalizations after a myocardial infarction (MI) were related to the MI, while the rest were due to other causes or for unclear reasons, a study ... reported. More than 40% of 30-day rehospitalizations after a myocardial
Troponin alone was highly effective at ruling out acute myocardial infarction and adverse cardiac events within 30 days but would have missed 3 cases of unstable angina, the study found. ... Patients with ST-elevation myocardial infarction were excluded
Many patients who are on home warfarin do not receive guideline-recommended treatment when they have a non-ST-segment elevation myocardial infarction (NSTEMI), a new study found.